iSpecimen Inc (ISPC)
0.3801
-0.01
(-2.69%)
USD |
NASDAQ |
Jun 20, 11:16
iSpecimen Cash from Investing (Quarterly): 1.937M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.937M |
| December 31, 2023 | -0.723M |
| September 30, 2023 | 2.351M |
| June 30, 2023 | -0.068M |
| March 31, 2023 | -8.788M |
| December 31, 2022 | -1.642M |
| September 30, 2022 | -0.7721M |
| June 30, 2022 | -0.438M |
| March 31, 2022 | -0.3392M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.3042M |
| September 30, 2021 | -0.2908M |
| June 30, 2021 | -0.2283M |
| March 31, 2021 | -0.2145M |
| December 31, 2020 | -0.2367M |
| September 30, 2020 | -0.2739M |
| June 30, 2020 | -0.3318M |
| March 31, 2020 | -0.2602M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.788M
Minimum
Mar 2023
2.351M
Maximum
Sep 2023
-0.6249M
Average
-0.2908M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| RadNet Inc | -60.94M |
| DermTech Inc | 7.834M |
| 23andMe Holding Co | -2.146M |
| Sera Prognostics Inc | -5.689M |
| Progyny Inc | 19.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.072M |
| Cash from Financing (Quarterly) | -0.1189M |
| Free Cash Flow | -8.536M |
| Free Cash Flow Per Share (Quarterly) | -0.2581 |
| Free Cash Flow to Equity (Quarterly) | -2.357M |
| Free Cash Flow Yield | -247.4% |